Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies.

MLA

Esquirol, A., et al. “Single-Agent GvHD Prophylaxis with Tacrolimus after Post-Transplant High-Dose Cyclophosphamide Is a Valid Option for Haploidentical Transplantation in Adults with Hematological Malignancies.” Bone Marrow Transplantation, vol. 52, no. 9, Sept. 2017, pp. 1273–79. EBSCOhost, https://doi.org/10.1038/bmt.2017.111.

APA

Esquirol, A., Pascual, M. J., Ortiz, M., Piñana, J. L., Ferra, C., Garcia Cadenas, I., Vilades, I., Brunet, S., Martino, R., & Sierra, J. (2017). Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies. Bone Marrow Transplantation, 52(9), 1273–1279. https://doi.org/10.1038/bmt.2017.111

Chicago

Esquirol, A, M J Pascual, M Ortiz, J L Piñana, C Ferra, I Garcia Cadenas, I Vilades, S Brunet, R Martino, and J Sierra. 2017. “Single-Agent GvHD Prophylaxis with Tacrolimus after Post-Transplant High-Dose Cyclophosphamide Is a Valid Option for Haploidentical Transplantation in Adults with Hematological Malignancies.” Bone Marrow Transplantation 52 (9): 1273–79. doi:10.1038/bmt.2017.111.